Pep2Dia® Gummies
Maintaining normal blood glucose levels
Offer a gummy formula combining Pep2Dia® and chromium, designed to meet the demands of the dietary supplements market in relation to blood sugar balance. Chromium helps maintain normal blood sugar levels and supports the normal metabolism of macronutrients. A private-label formula in gummy form with an apple flavour, to be taken once daily one gummy in the morning and one in the evening.
Formula
| Ingredients | For 2 gummies | RI* |
|---|---|---|
| Pep2Dia® milk protein hydrolysate | 1400 mg | - |
| Chrome | 40 μg | 100 % |
Claims
- Chromium helps maintain normal blood glucose levels and supports the normal metabolism of macronutrients.
Features
| Flavor | Apple |
| Size | 6 g |
| Finish | Oiled |
| Shelf life | 24 months |
Properties
Pep2Dia® & Chromium Apple-Flavoured Gummies - Blood Sugar Balance
Expand your range of dietary supplements with these gummies combining Pep2Dia® and chromium, a formula designed for the metabolic balance segment. Each gummy provides 720 mg of Pep2Dia® and 40 µg of chromium, representing 100 per cent of the reference intake for chromium.
The formula combines Pep2Dia® milk protein hydrolysate with chromium picolinate. Chromium has an authorised health claim: it helps maintain normal blood glucose levels and supports the normal metabolism of macronutrients.
Available in apple-flavoured gummies, the product is taken at a rate of two gummies per day and is supplied in a jar of 60 gummies. A private-label solution enabling laboratories and brands to expand their range with a formula focused on blood sugar balance and metabolism.
Pep2Dia® Clinical Studies
Pep2Dia® is a whey protein hydrolysate of dairy origin, developed from French milk. In particular, it contains a bioactive dipeptide, alanine-proline (AP), which has been studied for its effect on alpha-glucosidase, a digestive enzyme involved in the conversion of carbohydrates into glucose.
Its benefits are supported by several clinical studies conducted in subjects with high blood glucose levels or prediabetes. In particular, a randomised, double-blind, placebo-controlled study evaluated doses of 700 mg and 1,400 mg of Pep2Dia® prior to a high-carbohydrate meal, with a significant reduction in postprandial blood glucose levels observed at the dose studied.
A further study also assessed prolonged supplementation with 1,400 mg per day for 6 weeks in prediabetic individuals, showing, in particular, a favourable trend in HbA1c levels.
Pep2Dia® is therefore a distinctive active ingredient for the development of food supplements designed to support blood glucose balance and targeted nutritional formulations, with a positioning based on a patented and scientifically validated dairy ingredient.
Source: Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects, Nutrients, 2019.
ClinicalTrials.gov, NCT04375449 – Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects.
ClinicalTrials.gov, NCT05391854 – Étude clinique visant à évaluer l'effet à long terme de Pep2Dia® sur l'homéostasie glycémique chez des sujets prédiabétiques.
